TNNT2 and amyotrophic lateral sclerosis: The median monthly increase of cTnT was 0.045 points (IQR 0.02–0.08) in the control ALS cohort and 0.01 points (IQR −0.01–0.03) in the tofersen group (p = 0.0013).